These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 34206456)

  • 1. Lewy Body Dementias: A Coin with Two Sides?
    Milán-Tomás Á; Fernández-Matarrubia M; Rodríguez-Oroz MC
    Behav Sci (Basel); 2021 Jun; 11(7):. PubMed ID: 34206456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
    Jellinger KA; Korczyn AD
    BMC Med; 2018 Mar; 16(1):34. PubMed ID: 29510692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia.
    Gomperts SN
    Continuum (Minneap Minn); 2016 Apr; 22(2 Dementia):435-63. PubMed ID: 27042903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are there morphological differences between Parkinson's disease-dementia and dementia with Lewy bodies?
    Jellinger KA
    Parkinsonism Relat Disord; 2022 Jul; 100():24-32. PubMed ID: 35691178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral symptomatology and psychopharmacology of Lewy body dementia.
    Tampi RR; Young JJ; Tampi D
    Handb Clin Neurol; 2019; 165():59-70. PubMed ID: 31727230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias.
    Datta A; Chai YL; Tan JM; Lee JH; Francis PT; Chen CP; Sze SK; Lai MKP
    Mol Brain; 2017 Aug; 10(1):36. PubMed ID: 28800743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders.
    Irwin DJ; Hurtig HI
    J Alzheimers Dis Parkinsonism; 2018; 8(4):. PubMed ID: 30473927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions.
    Walker L; Stefanis L; Attems J
    J Neurochem; 2019 Sep; 150(5):467-474. PubMed ID: 30892688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.
    Hansen D; Ling H; Lashley T; Foley JA; Strand C; Eid TM; Holton JL; Warner TT
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):143-156. PubMed ID: 32720329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia.
    Jellinger KA
    J Neural Transm (Vienna); 2023 Jul; 130(7):891-904. PubMed ID: 37306790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].
    Bencs V; Bencze J; Módis VL; Simon V; Kálmán J; Hortobágyi T
    Orv Hetil; 2020 May; 161(18):727-737. PubMed ID: 32338488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical associations of tau in Lewy body dementias: A systematic review and meta-analysis.
    Chin KS; Yassi N; Churilov L; Masters CL; Watson R
    Parkinsonism Relat Disord; 2020 Nov; 80():184-193. PubMed ID: 33260030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias.
    Bohnen NI; Müller MLTM; Frey KA
    Curr Neurol Neurosci Rep; 2017 Aug; 17(10):73. PubMed ID: 28808912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia.
    Bibl M; Mollenhauer B; Esselmann H; Lewczuk P; Klafki HW; Sparbier K; Smirnov A; Cepek L; Trenkwalder C; Rüther E; Kornhuber J; Otto M; Wiltfang J
    Brain; 2006 May; 129(Pt 5):1177-87. PubMed ID: 16600985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementias.
    Shellikeri S; Cho S; Cousins KAQ; Liberman M; Howard E; Balganorth Y; Weintraub D; Spindler M; Deik A; Lee EB; Trojanowski JQ; Irwin D; Wolk D; Grossman M; Nevler N
    Parkinsonism Relat Disord; 2022 Sep; 102():94-100. PubMed ID: 35985146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory panel cytokines are elevated in the neocortex of late-stage Alzheimer's disease but not Lewy body dementias.
    Chai YL; Lee JH; Chong JR; Ballard C; Francis PT; Kennedy BK; Arumugam TV; Chen CP; Aarsland D; Lai MKP
    J Neuroinflammation; 2023 May; 20(1):111. PubMed ID: 37158957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroencephalogram in dementia with Lewy bodies: a systematic review.
    Chatzikonstantinou S; McKenna J; Karantali E; Petridis F; Kazis D; Mavroudis I
    Aging Clin Exp Res; 2021 May; 33(5):1197-1208. PubMed ID: 32383032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies.
    Tu H; Zhang ZW; Qiu L; Lin Y; Jiang M; Chia SY; Wei Y; Ng ASL; Reynolds R; Tan EK; Zeng L
    BMC Neurosci; 2022 Jan; 23(1):3. PubMed ID: 34983390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.